Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASRT | ZTS | TAK | GRFS | NBIX |
| Company | Assertio Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Grifols S.A. ADR | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.8613 | 150.97 | 13.15 | 6.33 | 139.37 |
| High | 0.8613 | 153.59 | 13.19 | 6.37 | 139.37 |
| Low | 0.7324 | 150.04 | 13.07 | 6.12 | 136.06 |
| Last | 0.7800 | 153.15 | 13.09 | 6.26 | 137.03 |
| Change | -0.0856 | +2.27 | -0.14 | -0.13 | -1.94 |
| % Change | -9.89% | +1.50% | -1.06% | -2.03% | -1.40% |
| Volume | 2,714,306 | 3,162,895 | 1,087,119 | 889,422 | 404,593 |
| 20-Day Average Volume | 789,870 | 4,111,873 | 1,729,259 | 1,354,331 | 774,066 |
| Previous Close | 0.8656 | 150.88 | 13.23 | 6.39 | 138.97 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8721 | 157.90 | 13.43 | 6.69 | 136.50 |
| 20-Day Raw Stochastic | 18.57% | 32.54% | 4.46% | 12.70% | 42.91% |
| 20-Day Relative Strength | 40.59% | 37.69% | 34.51% | 42.67% | 50.16% |
| Weighted Alpha | -66.35 | -18.24 | -21.66 | -4.54 | +36.31 |
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | 100% Sell | 96% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | 100% Sell | 96% Buy |
| Last Month's Opinion | 40% Sell | 40% Sell | 56% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.22% since 04/18/24 | +0.17% since 04/18/24 | -0.38% since 04/18/24 | -3.90% since 04/18/24 | +3.00% since 04/18/24 |
| Low | 0.7324 on 04/25/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 6.13 on 04/25/24 | 130.13 on 04/19/24 |
| High | 0.9400 on 04/23/24 | 153.59 on 04/25/24 | 13.41 on 04/23/24 | 6.66 on 04/23/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | -24.44% since 03/25/24 | -8.60% since 03/25/24 | -7.35% since 03/25/24 | -1.18% since 03/25/24 | -2.67% since 03/25/24 |
| Low | 0.7324 on 04/25/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 6.13 on 04/25/24 | 130.13 on 04/19/24 |
| High | 1.0600 on 03/27/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 7.35 on 04/09/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | -11.29% since 01/25/24 | -18.12% since 01/25/24 | -10.39% since 01/25/24 | -17.63% since 01/25/24 | -3.19% since 01/25/24 |
| Low | 0.7324 on 04/25/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 5.30 on 03/06/24 | 128.00 on 02/07/24 |
| High | 1.2100 on 03/12/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 9.37 on 02/28/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | -63.62% since 10/25/23 | -6.29% since 10/25/23 | -9.59% since 10/25/23 | -19.01% since 10/25/23 | +26.13% since 10/25/23 |
| Low | 0.7324 on 04/25/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 5.30 on 03/06/24 | 103.63 on 11/10/23 |
| High | 2.3700 on 11/06/23 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 12.15 on 12/29/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 82,338 | 69,006,328 | 41,870,544 | 4,393,509 | 13,828,489 |
| Shares Outstanding, K | 95,122 | 457,359 | 3,164,818 | 687,560 | 99,507 |
| Annual Sales | 152,070,000 | 8,544,000,000 | 29,803,340,000 | 7,134,500,000 | 1,887,100,000 |
| Annual Net Income | -331,940,000 | 2,344,000,000 | 2,345,930,000 | 131,340,000 | 249,700,000 |
| Last Quarter Sales | 32,990,000 | 2,213,000,000 | 7,556,070,000 | 2,025,030,000 | 515,200,000 |
| Last Quarter Net Income | -57,380,000 | 525,000,000 | 718,900,000 | 125,920,000 | 147,700,000 |
| 60-Month Beta | 0.96 | 0.85 | 0.53 | 0.56 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.11 on 03/11/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 0.09 on 07/27/23 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 05/09/24 | 03/05/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 7.00 | 28.11 | 6.86 | 0.00 | 57.89 |